| GlaxoSmithKline To Start Shipping
Untested H1N1 Vaccines Next Week
GlaxoSmithKline who have not completed any clinical trials to
assess the safety of H1N1 vaccines, expects to start shipping
out its vaccine next week to governments across Europe so that
mass vaccinations against the virus can begin.
Governments and drugmakers have been scrambling for vaccines
to combat the new H1N1 flu strain before a fear hyped second wave
of infection hits the northern hemisphere in the winter.
The world's second biggest pharmaceutical company said on Wednesday
it will begin shipments of its Pandemrix
vaccine from next week, after getting official clearance from
the European Commission on Tuesday.
According to infectious disease experts, due to delayed and potentially
serious side effects, the timelines for effective safety testing
on adjuvanted vaccines should span years from initial clinical
trials. Yet the vaccines about to be shipped to Europeans offer
no data or conclusive evidence to health regulators on vaccine
safety.
A full list of ingredients, warnings and side effects for all
H1N1 vaccine inserts is available
here.
European officials also gave a green light to Swiss drugmaker
Novartis for its H1N1 shot Focetria which also contains untested
and dangerous adjuvants
such as MF59.
Reference Sources 89
September 30, 2009
 ...............................................................................................................
|
